{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:50:40Z","timestamp":1783644640706,"version":"3.55.0"},"reference-count":162,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Rev and Rep"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s12015-025-10958-w","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T06:48:53Z","timestamp":1756968533000},"page":"2529-2547","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Gut Microbiome and its Impact on Outcomes following Hematopoietic Stem Cell Transplantation: a Comprehensive Review"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5001-5006","authenticated-orcid":false,"given":"Babak","family":"Arjmand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8584-851X","authenticated-orcid":false,"given":"Sana","family":"Badamchizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pouya","family":"Mehran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maedeh","family":"Sarvari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4488-9131","authenticated-orcid":false,"given":"Sepideh","family":"Alavi-Moghadam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasta","family":"Arjmand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1767-7475","authenticated-orcid":false,"given":"Mostafa","family":"Rezaei-Tavirani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghasem","family":"Janbabaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Vaezi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5386-7597","authenticated-orcid":false,"given":"Bagher","family":"Larijani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,4]]},"reference":[{"key":"10958_CR1","unstructured":"Sureda, A. The EBMT Handbook."},{"issue":"5","key":"10958_CR2","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/sj.bmt.1705265","volume":"37","author":"P Ljungman","year":"2006","unstructured":"Ljungman, P., et al. (2006). Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: Definitions and current practice in Europe. Bone Marrow Transplantation, 37(5), 439\u2013449.","journal-title":"Bone Marrow Transplantation"},{"issue":"12","key":"10958_CR3","first-page":"4665","volume":"90","author":"MS Cairo","year":"1997","unstructured":"Cairo, M. S., & Wagner, J. E. (1997). Placental and\/or umbilical cord blood: an alternative source of hematopoietic stem cells for transplantation. Blood. The Journal of the American Society of Hematology, 90(12), 4665\u20134678.","journal-title":"The Journal of the American Society of Hematology"},{"issue":"1","key":"10958_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.12968\/hmed.2019.80.1.33","volume":"80","author":"K Balassa","year":"2019","unstructured":"Balassa, K., Danby, R., & Rocha, V. (2019). Haematopoietic stem cell transplants: Principles and indications. British Journal of Hospital Medicine, 80(1), 33\u201339.","journal-title":"British Journal of Hospital Medicine"},{"issue":"6","key":"10958_CR5","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3109\/02841869709001315","volume":"36","author":"T Ruutu","year":"1997","unstructured":"Ruutu, T. (1997). Allogeneic bone marrow transplantation for malignant haematological disorders editorial commentary on Olle ringd\u00e9n: Allogeneic bone marrow transplantation for haematological malignancies\u2013controversies and recent advances. Acta Oncologica,36(6), 547\u2013548.","journal-title":"Acta Oncologica"},{"key":"10958_CR6","doi-asserted-by":"crossref","unstructured":"Hogan, W. J., & Deeg, H. J. (2005). Stem cell transplantation: graft-mediated antileukemia effects. Adoptive Immunotherapy: Methods and Protocols, 421\u2013444.","DOI":"10.1385\/1-59259-862-5:421"},{"issue":"4","key":"10958_CR7","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1046\/j.1365-2141.1997.3073124.x","volume":"98","author":"P Guardiola","year":"1997","unstructured":"Guardiola, P., et al. (1997). Allogeneic bone marrow transplantation for agnogenic myeloid metaplasia. British Journal of Haematology, 98(4), 1004\u20131009.","journal-title":"British Journal of Haematology"},{"issue":"6","key":"10958_CR8","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/sj.bmt.1700922","volume":"20","author":"JL Byrne","year":"1997","unstructured":"Byrne, J. L., et al. (1997). Autologous GVHD following PBSCT, with evidence for a graft-versus-myeloma effect. Bone Marrow Transplantation, 20(6), 517\u2013520.","journal-title":"Bone Marrow Transplantation"},{"issue":"4","key":"10958_CR9","first-page":"51","volume":"112","author":"I Hilgendorf","year":"2015","unstructured":"Hilgendorf, I., et al. (2015). Long-term follow-up after allogeneic stem cell transplantation. Dtsch Arztebl Int, 112(4), 51\u201358.","journal-title":"Dtsch Arztebl Int"},{"issue":"5","key":"10958_CR10","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nrc.2018.10","volume":"18","author":"Y Shono","year":"2018","unstructured":"Shono, Y., & van den Brink, M. R. (2018). Gut microbiota injury in allogeneic Haematopoietic stem cell transplantation. Nature Reviews Cancer, 18(5), 283\u2013295.","journal-title":"Nature Reviews Cancer"},{"issue":"9","key":"10958_CR11","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1056\/NEJMoa1900623","volume":"382","author":"JU Peled","year":"2020","unstructured":"Peled, J. U., et al. (2020). Microbiota as predictor of mortality in allogeneic hematopoietic-cell transplantation. New England Journal of Medicine, 382(9), 822\u2013834.","journal-title":"New England Journal of Medicine"},{"key":"10958_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40168-019-0745-z","volume":"7","author":"AC Ingham","year":"2019","unstructured":"Ingham, A. C., et al. (2019). Specific gut microbiome members are associated with distinct immune markers in pediatric allogeneic hematopoietic stem cell transplantation. Microbiome,7, 1\u201322.","journal-title":"Microbiome"},{"issue":"7","key":"10958_CR13","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1182\/blood-2014-02-554725","volume":"124","author":"Y Taur","year":"2014","unstructured":"Taur, Y., et al. (2014). The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. Blood,124(7), 1174\u20131182.","journal-title":"Blood"},{"issue":"339","key":"10958_CR14","doi-asserted-by":"publisher","first-page":"339ra71","DOI":"10.1126\/scitranslmed.aaf2311","volume":"8","author":"Y Shono","year":"2016","unstructured":"Shono, Y., et al. (2016). Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice. Science Translational Medicine, 8(339), 339ra71\u2013339ra71.","journal-title":"Science Translational Medicine"},{"issue":"10","key":"10958_CR15","doi-asserted-by":"publisher","first-page":"3688","DOI":"10.3390\/ijms21103688","volume":"21","author":"P Vernocchi","year":"2020","unstructured":"Vernocchi, P., Chierico, F. D., & Putignani, L. (2020). Gut microbiota metabolism and interaction with food components. International Journal of Molecular Sciences, 21(10), 3688.","journal-title":"International Journal of Molecular Sciences"},{"issue":"6086","key":"10958_CR16","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1126\/science.1223490","volume":"336","author":"LV Hooper","year":"2012","unstructured":"Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012). Interactions between the microbiota and the immune system. Science,336(6086), 1268\u20131273.","journal-title":"Science"},{"key":"10958_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/cells12050793","author":"J Wang","year":"2023","unstructured":"Wang, J. (2023). Gut-microbiota-derived metabolites maintain gut and systemic immune homeostasis. Cells. https:\/\/doi.org\/10.3390\/cells12050793","journal-title":"Cells"},{"key":"10958_CR18","doi-asserted-by":"publisher","first-page":"114985","DOI":"10.1016\/j.biopha.2023.114985","volume":"164","author":"J Chu","year":"2023","unstructured":"Chu, J., et al. (2023). Immunological mechanisms of inflammatory diseases caused by gut microbiota dysbiosis: A review. Biomedicine & Pharmacotherapy, 164, 114985.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"4","key":"10958_CR19","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1016\/j.psj.2019.12.011","volume":"99","author":"MH Kogut","year":"2020","unstructured":"Kogut, M. H., Lee, A., & Santin, E. (2020). Microbiome and pathogen interaction with the immune system. Poultry Science, 99(4), 1906\u20131913.","journal-title":"Poultry Science"},{"issue":"1","key":"10958_CR20","doi-asserted-by":"publisher","first-page":"89196","DOI":"10.5662\/wjm.v14.i1.89196","volume":"14","author":"M Salvadori","year":"2024","unstructured":"Salvadori, M., & Rosso, G. (2024). Update on the gut microbiome in health and diseases. World Journal of Methodology,14(1), 89196.","journal-title":"World Journal of Methodology"},{"issue":"5","key":"10958_CR21","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1111\/bjh.16458","volume":"189","author":"A Rashidi","year":"2020","unstructured":"Rashidi, A., et al. (2020). An alpha-defensin gene single nucleotide polymorphism modulates the gut microbiota and may alter the risk of acute graft-versus-host disease. British Journal of Haematology,189(5), 926\u2013930.","journal-title":"British Journal of Haematology"},{"issue":"1","key":"10958_CR22","first-page":"3532756","volume":"2023","author":"M Chi","year":"2023","unstructured":"Chi, M., et al. (2023). Role of gut microbiota and oxidative stress in the progression of Transplant-Related complications following hematopoietic stem cell transplantation. Oxidative Medicine and Cellular Longevity, 2023(1), 3532756.","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"22","key":"10958_CR23","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1056\/NEJMra1609337","volume":"377","author":"R Zeiser","year":"2017","unstructured":"Zeiser, R., & Blazar, B. R. (2017). Acute graft-versus-host disease\u2014biologic process, prevention, and therapy. New England Journal of Medicine, 377(22), 2167\u20132179.","journal-title":"New England Journal of Medicine"},{"key":"10958_CR24","doi-asserted-by":"crossref","unstructured":"Holler, E., Greinix, H., & Zeiser, R. (2019). Acute graft-versus-host disease. The EBMT handbook: Hematopoietic stem cell transplantation and cellular therapies. 323\u2013330","DOI":"10.1007\/978-3-030-02278-5_43"},{"issue":"7","key":"10958_CR25","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/bmt.2015.16","volume":"50","author":"E Biagi","year":"2015","unstructured":"Biagi, E., et al. (2015). Gut microbiota trajectory in pediatric patients undergoing hematopoietic SCT. Bone Marrow Transplantation, 50(7), 992\u2013998.","journal-title":"Bone Marrow Transplantation"},{"issue":"2","key":"10958_CR26","doi-asserted-by":"publisher","first-page":"176e1","DOI":"10.1016\/j.jtct.2020.10.009","volume":"27","author":"R Jabr","year":"2021","unstructured":"Jabr, R., et al. (2021). Clostridioides difficile infection and risk of acute graft-versus-host disease among allogeneic hematopoietic stem cell transplantation recipients. Transplantation and Cellular Therapy,27(2), 176e1\u2013176e8.","journal-title":"Transplantation and Cellular Therapy"},{"key":"10958_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-016-1094-3","volume":"14","author":"VM Raghunathan","year":"2016","unstructured":"Raghunathan, V. M., Sheng, I., & Lim, S. H. (2016). Intestinal dysbiosis and allogeneic hematopoietic progenitor cell transplantation. Journal of Translational Medicine, 14, 1\u20136.","journal-title":"Journal of Translational Medicine"},{"key":"10958_CR28","unstructured":"Hoor, M. (2021). The Potential of targeting the gut microbiota to improve allogeneic haematopoietic stem cell transplantation outcomes, focusing on graft-versus-host diseases."},{"issue":"9","key":"10958_CR29","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1182\/bloodadvances.2020001531","volume":"4","author":"M Payen","year":"2020","unstructured":"Payen, M., et al. (2020). Functional and phylogenetic alterations in gut microbiome are linked to graft-versus-host disease severity. Blood Advances,4(9), 1824\u20131832.","journal-title":"Blood Advances"},{"issue":"1","key":"10958_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms7010014","volume":"7","author":"E Rinninella","year":"2019","unstructured":"Rinninella, E. (2019). What is the healthy gut microbiota composition?? A changing ecosystem across age, environment, diet, and diseases. Microorganisms,7(1), Article 14.","journal-title":"Microorganisms"},{"key":"10958_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40164-021-00240-3","volume":"10","author":"D Lin","year":"2021","unstructured":"Lin, D., et al. (2021). Roles of the intestinal microbiota and microbial metabolites in acute GVHD. Experimental Hematology & Oncology,10, 1\u201319.","journal-title":"Experimental Hematology & Oncology"},{"issue":"5","key":"10958_CR32","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1084\/jem.20112408","volume":"209","author":"RR Jenq","year":"2012","unstructured":"Jenq, R. R., et al. (2012). Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation. Journal of Experimental Medicine, 209(5), 903\u2013911.","journal-title":"Journal of Experimental Medicine"},{"issue":"2\u20133","key":"10958_CR33","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.beha.2015.10.013","volume":"28","author":"Y Taur","year":"2015","unstructured":"Taur, Y., et al. (2015). Role of intestinal microbiota in transplantation outcomes. Best Practice & Research Clinical Haematology,28(2\u20133), 155\u2013161.","journal-title":"Best Practice & Research Clinical Haematology"},{"key":"10958_CR34","doi-asserted-by":"publisher","first-page":"719072","DOI":"10.3389\/fcell.2021.719072","volume":"9","author":"H Tudela","year":"2021","unstructured":"Tudela, H., Claus, S. P., & Saleh, M. (2021). Next generation microbiome research: Identification of keystone species in the metabolic regulation of host-gut microbiota interplay. Frontiers in Cell and Developmental Biology,9, 719072.","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"1","key":"10958_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2020.1848158","volume":"13","author":"H Zafar","year":"2021","unstructured":"Zafar, H., & SaierJr., M. H. (2021). Gut bacteroides species in health and disease. Gut Microbes, 13(1), 1\u201320.","journal-title":"Gut Microbes"},{"issue":"1","key":"10958_CR36","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s40168-024-01948-0","volume":"12","author":"A Artacho","year":"2024","unstructured":"Artacho, A., et al. (2024). Multimodal analysis identifies microbiome changes linked to stem cell transplantation-associated diseases. Microbiome,12(1), 229.","journal-title":"Microbiome"},{"issue":"8","key":"10958_CR37","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1172\/JCI32205","volume":"117","author":"CM Paulos","year":"2007","unstructured":"Paulos, C. M., et al. (2007). Microbial translocation augments the function of adoptively transferred self\/tumor-specific CD8\u2009+\u2009T cells via TLR4 signaling. The Journal of Clinical Investigation, 117(8), 2197\u20132204.","journal-title":"The Journal of Clinical Investigation"},{"issue":"5","key":"10958_CR38","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/apt.13302","volume":"42","author":"E Montassier","year":"2015","unstructured":"Montassier, E., et al. (2015). Chemotherapy-driven dysbiosis in the intestinal microbiome. Alimentary Pharmacology & Therapeutics,42(5), 515\u2013528.","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"2","key":"10958_CR39","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1086\/599346","volume":"49","author":"MJ van Vliet","year":"2009","unstructured":"van Vliet, M. J., et al. (2009). Chemotherapy treatment in pediatric patients with acute myeloid leukemia receiving antimicrobial prophylaxis leads to a relative increase of colonization with potentially pathogenic bacteria in the gut. Clinical Infectious Diseases, 49(2), 262\u2013270.","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"10958_CR40","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1158\/1078-0432.CCR-22-1254","volume":"29","author":"R Shouval","year":"2023","unstructured":"Shouval, R., et al. (2023). Conditioning regimens are associated with distinct patterns of microbiota injury in allogeneic hematopoietic cell transplantation. Clinical Cancer Research, 29(1), 165\u2013173.","journal-title":"Clinical Cancer Research"},{"issue":"4","key":"10958_CR41","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.jcmgh.2021.06.006","volume":"12","author":"P Cray","year":"2021","unstructured":"Cray, P., Sheahan, B. J., & Dekaney, C. M. (2021). Secretory sorcery: Paneth cell control of intestinal repair and homeostasis. Cellular and Molecular Gastroenterology and Hepatology, 12(4), 1239\u20131250.","journal-title":"Cellular and Molecular Gastroenterology and Hepatology"},{"issue":"12","key":"10958_CR42","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.3390\/nu11122958","volume":"11","author":"F D\u2019Amico","year":"2019","unstructured":"D\u2019Amico, F., et al. (2019). Enteral nutrition in pediatric patients undergoing hematopoietic SCT promotes the recovery of gut microbiome homeostasis. Nutrients,11(12), 2958.","journal-title":"Nutrients"},{"issue":"5","key":"10958_CR43","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1111\/bjh.12332","volume":"161","author":"G Finazzi","year":"2013","unstructured":"Finazzi, G., et al. (2013). A phase II study of G ivinostat in combination with hydroxycarbamide in patients with polycythaemia vera unresponsive to hydroxycarbamide monotherapy. British Journal of Haematology,161(5), 688\u2013694.","journal-title":"British Journal of Haematology"},{"issue":"2","key":"10958_CR44","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.clnu.2018.03.008","volume":"38","author":"J Beckerson","year":"2019","unstructured":"Beckerson, J., et al. (2019). Impact of route and adequacy of nutritional intake on outcomes of allogeneic haematopoietic cell transplantation for haematologic malignancies. Clinical Nutrition,38(2), 738\u2013744.","journal-title":"Clinical Nutrition"},{"issue":"6","key":"10958_CR45","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1016\/j.clnu.2017.10.005","volume":"37","author":"F Gonzales","year":"2018","unstructured":"Gonzales, F., et al. (2018). Better early outcome with enteral rather than parenteral nutrition in children undergoing MAC allo-SCT. Clinical Nutrition, 37(6), 2113\u20132121.","journal-title":"Clinical Nutrition"},{"key":"10958_CR46","doi-asserted-by":"publisher","first-page":"100614","DOI":"10.1016\/j.blre.2019.100614","volume":"39","author":"PP Chong","year":"2020","unstructured":"Chong, P. P., & Koh, A. Y. (2020). The gut microbiota in transplant patients. Blood Reviews, 39, 100614.","journal-title":"Blood Reviews"},{"issue":"7","key":"10958_CR47","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1093\/cid\/cis580","volume":"55","author":"Y Taur","year":"2012","unstructured":"Taur, Y., et al. (2012). Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clinical Infectious Diseases, 55(7), 905\u2013914.","journal-title":"Clinical Infectious Diseases"},{"issue":"5","key":"10958_CR48","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.bbmt.2017.02.006","volume":"23","author":"D Weber","year":"2017","unstructured":"Weber, D., et al. (2017). Microbiota disruption induced by early use of broad-spectrum antibiotics is an independent risk factor of outcome after allogeneic stem cell transplantation. Biology of Blood and Marrow Transplantation, 23(5), 845\u2013852.","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"9","key":"10958_CR49","doi-asserted-by":"publisher","first-page":"e00206","DOI":"10.1128\/iai00206.19","volume":"87","author":"S Morjaria","year":"2019","unstructured":"Morjaria, S., et al. (2019). Antibiotic-induced shifts in fecal microbiota density and composition during hematopoietic stem cell transplantation. Infection and immunity, 87(9), e00206. https:\/\/doi.org\/10.1128\/iai00206.19","journal-title":"Infection and immunity"},{"key":"10958_CR50","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s10620-018-5369-9","volume":"64","author":"R Kumari","year":"2019","unstructured":"Kumari, R., Palaniyandi, S., & Hildebrandt, G. C. (2019). Microbiome: An emerging new frontier in graft-versus-host disease. Digestive Diseases and Sciences, 64, 669\u2013677.","journal-title":"Digestive Diseases and Sciences"},{"issue":"1","key":"10958_CR51","doi-asserted-by":"publisher","first-page":"2178805","DOI":"10.1080\/19490976.2023.2178805","volume":"15","author":"YF van Lier","year":"2023","unstructured":"van Lier, Y. F., et al. (2023). Allogeneic hematopoietic cell transplantation, the microbiome, and graft-versus-host disease. Gut Microbes, 15(1), 2178805.","journal-title":"Gut Microbes"},{"issue":"8","key":"10958_CR52","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.bbmt.2015.04.016","volume":"21","author":"RR Jenq","year":"2015","unstructured":"Jenq, R. R., et al. (2015). Intestinal Blautia is associated with reduced death from graft-versus-host disease. Biology of Blood and Marrow Transplantation,21(8), 1373\u20131383.","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"1","key":"10958_CR53","first-page":"223","volume":"120","author":"Y Eriguchi","year":"2012","unstructured":"Eriguchi, Y., et al. (2012). Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of \u03b1-defensins. Blood. The Journal of the American Society of Hematology, 120(1), 223\u2013231.","journal-title":"The Journal of the American Society of Hematology"},{"issue":"15","key":"10958_CR54","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1200\/JCO.2016.70.3348","volume":"35","author":"JU Peled","year":"2017","unstructured":"Peled, J. U., et al. (2017). Intestinal microbiota and relapse after hematopoietic-cell transplantation. Journal of Clinical Oncology, 35(15), 1650\u20131659.","journal-title":"Journal of Clinical Oncology"},{"issue":"5","key":"10958_CR55","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/ni.3400","volume":"17","author":"ND Mathewson","year":"2016","unstructured":"Mathewson, N. D., et al. (2016). Gut microbiome\u2013derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease. Nature Immunology, 17(5), 505\u2013513.","journal-title":"Nature Immunology"},{"issue":"11","key":"10958_CR56","doi-asserted-by":"publisher","first-page":"3786","DOI":"10.1128\/IAI.00647-12","volume":"80","author":"AE Reeves","year":"2012","unstructured":"Reeves, A. E., et al. (2012). Suppression of clostridium difficile in the Gastrointestinal tracts of germfree mice inoculated with a murine isolate from the family lachnospiraceae. Infection and Immunity,80(11), 3786\u20133794.","journal-title":"Infection and Immunity"},{"issue":"7461","key":"10958_CR57","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nature12331","volume":"500","author":"K Atarashi","year":"2013","unstructured":"Atarashi, K., et al. (2013). Treg induction by a rationally selected mixture of clostridia strains from the human microbiota. Nature,500(7461), 232\u2013236.","journal-title":"Nature"},{"issue":"9","key":"10958_CR58","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s44222-023-00072-2","volume":"1","author":"X Bai","year":"2023","unstructured":"Bai, X., et al. (2023). Engineering the gut microbiome. Nature Reviews Bioengineering,1(9), 665\u2013679.","journal-title":"Nature Reviews Bioengineering"},{"key":"10958_CR59","doi-asserted-by":"publisher","first-page":"100790","DOI":"10.1016\/j.blre.2020.100790","volume":"48","author":"S Ciernikova","year":"2021","unstructured":"Ciernikova, S., et al. (2021). Targeting the gut microbiome: An emerging trend in hematopoietic stem cell transplantation. Blood Reviews, 48, 100790.","journal-title":"Blood Reviews"},{"key":"10958_CR60","doi-asserted-by":"crossref","unstructured":"Stein-Thoeringer, C., et al. (2018). Domination of the gut microbiota with <\u2009em\u2009>\u2009enterococcus\u2009species early after allogeneic bone marrow transplantation is an important contributor to the development of acute Graft-Versus-Host disease (GHVD) in mouse and man (Vol. 24, pp. S40\u2013S41). Biology of Blood and Marrow Transplantation. 3.","DOI":"10.1016\/j.bbmt.2017.12.594"},{"issue":"16","key":"10958_CR61","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1182\/blood.2023020026","volume":"142","author":"R Masetti","year":"2023","unstructured":"Masetti, R., et al. (2023). Gut microbiota diversity before allogeneic hematopoietic stem cell transplantation as a predictor of mortality in children. Blood, 142(16), 1387\u20131398.","journal-title":"Blood"},{"issue":"8","key":"10958_CR62","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1182\/blood-2016-09-691394","volume":"129","author":"A Staffas","year":"2017","unstructured":"Staffas, A., Burgos da, M., Silva, & van den Brink, M. R. M. (2017). The intestinal microbiota in allogeneic hematopoietic cell transplant and graft-versus-host disease. Blood, 129(8), 927\u2013933.","journal-title":"Blood"},{"issue":"1","key":"10958_CR63","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s40168-019-0745-z","volume":"7","author":"AC Ingham","year":"2019","unstructured":"Ingham, A. C., et al. (2019). Specific gut microbiome members are associated with distinct immune markers in pediatric allogeneic hematopoietic stem cell transplantation. Microbiome,7(1), 131.","journal-title":"Microbiome"},{"issue":"8","key":"10958_CR64","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1080\/14712598.2021.1872541","volume":"21","author":"CC Chang","year":"2021","unstructured":"Chang, C. C., Hayase, E., & Jenq, R. R. (2021). The role of microbiota in allogeneic hematopoietic stem cell transplantation. Expert Opinion on Biological Therapy, 21(8), 1121\u20131131.","journal-title":"Expert Opinion on Biological Therapy"},{"key":"10958_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnesp.2024.08.005","author":"V Shukla","year":"2024","unstructured":"Shukla, V., et al. (2024). Targeting the microbiome to improve human health with the approach of personalized medicine: Latest aspects and current updates. Clinical Nutrition ESPEN. https:\/\/doi.org\/10.1016\/j.clnesp.2024.08.005","journal-title":"Clinical Nutrition ESPEN"},{"issue":"2","key":"10958_CR66","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1007\/s43393-023-00208-w","volume":"4","author":"K Prajapati","year":"2024","unstructured":"Prajapati, K., et al. (2024). Advances in probiotics research: Mechanisms of action, health benefits, and limitations in applications. Systems Microbiology and Biomanufacturing, 4(2), 386\u2013406.","journal-title":"Systems Microbiology and Biomanufacturing"},{"issue":"1","key":"10958_CR67","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11899-016-0302-9","volume":"11","author":"TM Andermann","year":"2016","unstructured":"Andermann, T. M., Rezvani, A., & Bhatt, A. S. (2016). Microbiota manipulation with prebiotics and probiotics in patients undergoing stem cell transplantation. Current Hematologic Malignancy Reports, 11(1), 19\u201328.","journal-title":"Current Hematologic Malignancy Reports"},{"issue":"12","key":"10958_CR68","doi-asserted-by":"publisher","first-page":"7577","DOI":"10.1007\/s13197-015-1921-1","volume":"52","author":"KR Pandey","year":"2015","unstructured":"Pandey, K. R., Naik, S. R., & Vakil, B. V. (2015). Probiotics, prebiotics and synbiotics- A review. Journal of Food Science and Technology,52(12), 7577\u20137587.","journal-title":"Journal of Food Science and Technology"},{"issue":"1","key":"10958_CR69","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s40164-020-00194-y","volume":"9","author":"J Yu","year":"2020","unstructured":"Yu, J., et al. (2020). Applications of gut microbiota in patients with hematopoietic stem-cell transplantation. Experimental Hematology & Oncology,9(1), 35.","journal-title":"Experimental Hematology & Oncology"},{"key":"10958_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.993668","author":"E Muratore","year":"2022","unstructured":"Muratore, E. (2022). Nutritional modulation of the gut microbiome in allogeneic hematopoietic stem cell transplantation recipients. Frontiers in Nutrition. https:\/\/doi.org\/10.3389\/fnut.2022.993668","journal-title":"Frontiers in Nutrition"},{"issue":"7","key":"10958_CR71","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.bbmt.2018.02.009","volume":"24","author":"TM Andermann","year":"2018","unstructured":"Andermann, T. M., et al. (2018). The microbiome and hematopoietic cell transplantation: Past, present, and future. Biology of Blood and Marrow Transplantation,24(7), 1322\u20131340.","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"3","key":"10958_CR72","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jtct.2021.12.015","volume":"28","author":"R Bansal","year":"2022","unstructured":"Bansal, R., et al. (2022). Antibiotic exposure, not alloreactivity, is the major driver of microbiome changes in hematopoietic cell transplantation. Transplantation and Cellular Therapy,28(3), 135\u2013144.","journal-title":"Transplantation and Cellular Therapy"},{"key":"10958_CR73","doi-asserted-by":"publisher","first-page":"988121","DOI":"10.3389\/fimmu.2022.988121","volume":"13","author":"AE Wolfe","year":"2022","unstructured":"Wolfe, A. E., & Markey, K. A. (2022). The contribution of the intestinal microbiome to immune recovery after HCT. Frontiers in Immunology,13, 988121.","journal-title":"Frontiers in Immunology"},{"issue":"4","key":"10958_CR74","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/fbe2.12107","volume":"3","author":"T Kumari","year":"2024","unstructured":"Kumari, T., et al. (2024). Synergistic role of prebiotics and probiotics in gut microbiome health: Mechanisms and clinical applications. Food Bioengineering,3(4), 407\u2013424.","journal-title":"Food Bioengineering"},{"issue":"1","key":"10958_CR75","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s10020-024-01060-x","volume":"31","author":"M Azhar Ud Din","year":"2025","unstructured":"Azhar Ud Din, M., et al. (2025). Advancing therapeutic strategies for graft-versus-host disease by targeting gut microbiome dynamics in allogeneic hematopoietic stem cell transplantation: Current evidence and future directions. Molecular Medicine,31(1), 2.","journal-title":"Molecular Medicine"},{"key":"10958_CR76","doi-asserted-by":"publisher","first-page":"1439176","DOI":"10.3389\/fimmu.2024.1439176","volume":"15","author":"M Karimi","year":"2024","unstructured":"Karimi, M., et al. (2024). Safety and efficacy of fecal microbiota transplantation (FMT) as a modern adjuvant therapy in various diseases and disorders: A comprehensive literature review. Frontiers in Immunology,15, 1439176.","journal-title":"Frontiers in Immunology"},{"issue":"3","key":"10958_CR77","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.6799","volume":"13","author":"X Yue","year":"2024","unstructured":"Yue, X., et al. (2024). Gut microbiota, microbiota-derived metabolites, and graft-versus-host disease. Cancer Medicine,13(3), Article e6799.","journal-title":"Cancer Medicine"},{"issue":"1","key":"10958_CR78","doi-asserted-by":"publisher","DOI":"10.3390\/immuno5010010","volume":"5","author":"P Pinzon-Leal","year":"2025","unstructured":"Pinzon-Leal, P., et al. (2025). The microbiome, inflammation, and GVHD axis: The balance between the gut and the bad. Immuno,5(1), Article 10.","journal-title":"Immuno"},{"key":"10958_CR79","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jnutbio.2018.07.010","volume":"61","author":"S Mukherjee","year":"2018","unstructured":"Mukherjee, S., et al. (2018). Gut microbes as future therapeutics in treating inflammatory and infectious diseases: Lessons from recent findings. Journal of Nutritional Biochemistry, 61, 111\u2013128.","journal-title":"Journal of Nutritional Biochemistry"},{"key":"10958_CR80","doi-asserted-by":"publisher","first-page":"101836","DOI":"10.1016\/j.trim.2023.101836","volume":"78","author":"E Yazdandoust","year":"2023","unstructured":"Yazdandoust, E., et al. (2023). Gut microbiota intervention by pre and probiotics can induce regulatory T cells and reduce the risk of severe acute GVHD following allogeneic hematopoietic stem cell transplantation. Transplant Immunology, 78, 101836.","journal-title":"Transplant Immunology"},{"issue":"7","key":"10958_CR81","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1182\/bloodadvances.2018017731","volume":"2","author":"Z DeFilipp","year":"2018","unstructured":"DeFilipp, Z., et al. (2018). Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity. Blood Advances,2(7), 745\u2013753.","journal-title":"Blood Advances"},{"issue":"460","key":"10958_CR82","doi-asserted-by":"publisher","first-page":"eaap9489","DOI":"10.1126\/scitranslmed.aap9489","volume":"10","author":"Y Taur","year":"2018","unstructured":"Taur, Y., et al. (2018). Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant. Science Translational Medicine, 10(460), eaap9489.","journal-title":"Science Translational Medicine"},{"issue":"19","key":"10958_CR83","doi-asserted-by":"publisher","first-page":"4607","DOI":"10.1182\/bloodadvances.2020002604","volume":"4","author":"K Yoshifuji","year":"2020","unstructured":"Yoshifuji, K., et al. (2020). Prebiotics protect against acute graft-versus-host disease and preserve the gut microbiota in stem cell transplantation. Blood Advances, 4(19), 4607\u20134617.","journal-title":"Blood Advances"},{"issue":"5","key":"10958_CR84","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1159\/000492943","volume":"11","author":"F Noor","year":"2018","unstructured":"Noor, F., et al. (2018). The gut microbiota and hematopoietic stem cell transplantation: Challenges and potentials. Journal of Innate Immunity, 11(5), 405\u2013415.","journal-title":"Journal of Innate Immunity"},{"issue":"11","key":"10958_CR85","doi-asserted-by":"publisher","first-page":"4365","DOI":"10.1182\/blood-2003-11-3769","volume":"103","author":"A Gerbitz","year":"2004","unstructured":"Gerbitz, A., et al. (2004). Probiotic effects on experimental graft-versus-host disease: Let them eat yogurt. Blood, 103(11), 4365\u20134367.","journal-title":"Blood"},{"issue":"2","key":"10958_CR86","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/bmt.2015.275","volume":"51","author":"E Ladas","year":"2016","unstructured":"Ladas, E., et al. (2016). The safety and feasibility of probiotics in children and adolescents undergoing hematopoietic cell transplantation. Bone Marrow Transplantation,51(2), 262\u2013266.","journal-title":"Bone Marrow Transplantation"},{"issue":"5","key":"10958_CR87","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.12947","volume":"31","author":"E Gorshein","year":"2017","unstructured":"Gorshein, E., et al. (2017). Lactobacillus rhamnosus GG probiotic enteric regimen does not appreciably alter the gut microbiome or provide protection against GVHD after allogeneic hematopoietic stem cell transplantation. Clinical Transplantation,31(5), Article e12947.","journal-title":"Clinical Transplantation"},{"key":"10958_CR88","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.136841","author":"MH Sofi","year":"2021","unstructured":"Sofi, M. H. (2021). A single strain of bacteroides fragilis protects gut integrity and reduces GVHD. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.136841","journal-title":"JCI Insight"},{"issue":"2","key":"10958_CR89","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s40121-019-0244-3","volume":"8","author":"A Sadanand","year":"2019","unstructured":"Sadanand, A., Newland, J. G., & Bednarski, J. J. (2019). Safety of probiotics among high-risk pediatric hematopoietic stem cell transplant recipients. Infectious Diseases and Therapy,8(2), 301\u2013306.","journal-title":"Infectious Diseases and Therapy"},{"issue":"5","key":"10958_CR90","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1111\/tid.12587","volume":"18","author":"S Cohen","year":"2016","unstructured":"Cohen, S., et al. (2016). Incidence and outcomes of bloodstream infections among hematopoietic cell transplant recipients from species commonly reported to be in over-the\u2010counter probiotic formulations. Transplant Infectious Disease,18(5), 699\u2013705.","journal-title":"Transplant Infectious Disease"},{"issue":"3","key":"10958_CR91","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/bmt.2012.153","volume":"48","author":"A Mehta","year":"2013","unstructured":"Mehta, A., Rangarajan, S., & Borate, U. (2013). A cautionary tale for probiotic use in hematopoietic SCT patients-Lactobacillus acidophilus sepsis in a patient with mantle cell lymphoma undergoing hematopoietic SCT. Bone Marrow Transplantation,48(3), 461\u2013462.","journal-title":"Bone Marrow Transplantation"},{"issue":"1","key":"10958_CR92","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s12602-018-9399-6","volume":"11","author":"S Koyama","year":"2019","unstructured":"Koyama, S., et al. (2019). Septicemia from Lactobacillus rhamnosus GG, from a probiotic enriched yogurt, in a patient with autologous stem cell transplantation. Probiotics and Antimicrobial Proteins,11(1), 295\u2013298.","journal-title":"Probiotics and Antimicrobial Proteins"},{"key":"10958_CR93","doi-asserted-by":"crossref","unstructured":"Riwes, M. M. (2024). Rational modification of human gut microbiome and metabolites by dietary resistant starch in allogeneic hematopoietic stem cell transplantation to mitigate acute graft versus host disease: A phase II study clinical update. Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy.\u00a030(2), S28\u2013S29.","DOI":"10.1016\/j.jtct.2023.12.057"},{"issue":"11","key":"10958_CR94","doi-asserted-by":"publisher","first-page":"932.e1","DOI":"10.1016\/j.jtct.2021.07.009","volume":"27","author":"TM Andermann","year":"2021","unstructured":"Andermann, T. M., et al. (2021). A fructo-oligosaccharide prebiotic is well tolerated in adults undergoing allogeneic hematopoietic stem cell transplantation: A phase I dose-escalation trial. Transplantation and Cellular Therapy,27(11), 932.e1\u2013932.e11.","journal-title":"Transplantation and Cellular Therapy"},{"key":"10958_CR95","doi-asserted-by":"publisher","DOI":"10.3390\/biom12101443","author":"M Mounir","year":"2022","unstructured":"Mounir, M. (2022). Synbiotics and their antioxidant properties, mechanisms, and benefits on human and animal health: A narrative review. Biomolecules. https:\/\/doi.org\/10.3390\/biom12101443","journal-title":"Biomolecules"},{"issue":"11","key":"10958_CR96","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41575-020-0344-2","volume":"17","author":"KS Swanson","year":"2020","unstructured":"Swanson, K. S., et al. (2020). The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics. Nature Reviews Gastroenterology & Hepatology,17(11), 687\u2013701.","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"issue":"9","key":"10958_CR97","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s11274-024-04085-w","volume":"40","author":"S Lee","year":"2024","unstructured":"Lee, S., et al. (2024). A comprehensive review of synbiotics: An emerging paradigm in health promotion and disease management. World Journal of Microbiology & Biotechnology,40(9), 280.","journal-title":"World Journal of Microbiology & Biotechnology"},{"issue":"20","key":"10958_CR98","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.2169\/internalmedicine.1314-22","volume":"62","author":"Y Mizutani","year":"2023","unstructured":"Mizutani, Y., et al. (2023). Efficacy and safety of synbiotics in patients undergoing autologous hematopoietic stem cell transplantation: A randomized, double-blinded, placebo-controlled pilot study. Internal Medicine,62(20), 2949\u20132958.","journal-title":"Internal Medicine"},{"key":"10958_CR99","doi-asserted-by":"crossref","unstructured":"Singh, K. (2024). Introduction to synbiotics. Synbiotics in human health: Biology to drug delivery (pp. 3\u201323). Springer. K. Dua, Editor.","DOI":"10.1007\/978-981-99-5575-6_1"},{"issue":"1","key":"10958_CR100","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/microorganisms7010014","volume":"7","author":"E Rinninella","year":"2019","unstructured":"Rinninella, E., et al. (2019). What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms, 7(1), 14.","journal-title":"Microorganisms"},{"issue":"7346","key":"10958_CR101","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/nature09944","volume":"473","author":"M Arumugam","year":"2011","unstructured":"Arumugam, M., et al. (2011). Enterotypes of the human gut Microbiome. Nature, 473(7346), 174\u2013180.","journal-title":"Nature"},{"issue":"6","key":"10958_CR102","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/j.cell.2012.01.035","volume":"148","author":"JC Clemente","year":"2012","unstructured":"Clemente, J. C., et al. (2012). The impact of the gut microbiota on human health: An integrative view. Cell, 148(6), 1258\u20131270.","journal-title":"Cell"},{"issue":"2","key":"10958_CR103","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s12664-015-0547-6","volume":"34","author":"N Hajela","year":"2015","unstructured":"Hajela, N., et al. (2015). Gut microbiome, gut function, and probiotics: Implications for health. Indian Journal of Gastroenterology, 34(2), 93\u2013107.","journal-title":"Indian Journal of Gastroenterology"},{"issue":"11","key":"10958_CR104","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1038\/s41591-023-02587-y","volume":"29","author":"MM Riwes","year":"2023","unstructured":"Riwes, M. M., et al. (2023). Feasibility of a dietary intervention to modify gut microbial metabolism in patients with hematopoietic stem cell transplantation. Nature Medicine, 29(11), 2805\u20132813.","journal-title":"Nature Medicine"},{"issue":"3","key":"10958_CR105","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3390\/dietetics1030017","volume":"1","author":"V Biswas","year":"2022","unstructured":"Biswas, V., et al. (2022). A mechanistic overview on impact of dietary fibres on gut microbiota and its association with colon cancer. Dietetics, 1(3), 182\u2013202.","journal-title":"Dietetics"},{"key":"10958_CR106","doi-asserted-by":"publisher","DOI":"10.3390\/nu15153365","author":"S Hamamah","year":"2023","unstructured":"Hamamah, S. (2023). Dietary fat modulation of gut microbiota and impact on regulatory pathways controlling food intake. Nutrients. https:\/\/doi.org\/10.3390\/nu15153365","journal-title":"Nutrients"},{"issue":"22","key":"10958_CR107","doi-asserted-by":"publisher","first-page":"6225","DOI":"10.1080\/10408398.2021.1898336","volume":"62","author":"J Cai","year":"2022","unstructured":"Cai, J., et al. (2022). High animal protein diet and gut microbiota in human health. Critical Reviews in Food Science and Nutrition, 62(22), 6225\u20136237.","journal-title":"Critical Reviews in Food Science and Nutrition"},{"issue":"3","key":"10958_CR108","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.clnu.2018.09.016","volume":"38","author":"F Blachier","year":"2019","unstructured":"Blachier, F., et al. (2019). High-protein diets for weight management: Interactions with the intestinal microbiota and consequences for gut health. A position paper by the My new gut study group. Clinical Nutrition,38(3), 1012\u20131022.","journal-title":"Clinical Nutrition"},{"issue":"10","key":"10958_CR109","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.3390\/nu12103054","volume":"12","author":"AWC Man","year":"2020","unstructured":"Man, A. W. C., et al. (2020). Involvement of gut microbiota, microbial metabolites and interaction with polyphenol in host immunometabolism. Nutrients, 12(10), 3054.","journal-title":"Nutrients"},{"issue":"8","key":"10958_CR110","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.3390\/foods12081591","volume":"12","author":"E Kaewarsar","year":"2023","unstructured":"Kaewarsar, E., et al. (2023). Optimization of mixed inulin, fructooligosaccharides, and galactooligosaccharides as prebiotics for stimulation of probiotics growth and function. Foods, 12(8), 1591.","journal-title":"Foods"},{"key":"10958_CR111","doi-asserted-by":"crossref","unstructured":"Nourizadeh, R. (2022). Impact of probiotics in modulation of gut Microbiome. Microbiome-Gut-Brain Axis: Implications on Health, : pp. 401\u2013409.","DOI":"10.1007\/978-981-16-1626-6_20"},{"key":"10958_CR112","doi-asserted-by":"crossref","unstructured":"Kim, S. K. (2019). Role of probiotics in human gut microbiome-associated diseases.","DOI":"10.4014\/jmb.1906.06064"},{"issue":"2","key":"10958_CR113","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3390\/antiox10020188","volume":"10","author":"M Makarewicz","year":"2021","unstructured":"Makarewicz, M., et al. (2021). The interactions between polyphenols and microorganisms, especially gut microbiota. Antioxidants, 10(2), 188.","journal-title":"Antioxidants"},{"issue":"6","key":"10958_CR114","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.3390\/antiox11061212","volume":"11","author":"X Wang","year":"2022","unstructured":"Wang, X., Qi, Y., & Zheng, H. (2022). Dietary polyphenol, gut microbiota, and health benefits. Antioxidants, 11(6), 1212.","journal-title":"Antioxidants"},{"key":"10958_CR115","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.copbio.2019.10.008","volume":"61","author":"P DeMartino","year":"2020","unstructured":"DeMartino, P., & Cockburn, D. W. (2020). Resistant starch: Impact on the gut microbiome and health. Current Opinion in Biotechnology,61, 66\u201371.","journal-title":"Current Opinion in Biotechnology"},{"key":"10958_CR116","doi-asserted-by":"crossref","unstructured":"Chen, Z., et al. (2024). Resistant starch and the gut microbiome: Exploring beneficial interactions and dietary impacts (Vol. 21, p. 101118). X.","DOI":"10.1016\/j.fochx.2024.101118"},{"key":"10958_CR117","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12944-019-1167-4","volume":"19","author":"L Zhu","year":"2020","unstructured":"Zhu, L., et al. (2020). Dietary flaxseed oil rich in omega-3 suppresses severity of type 2 diabetes mellitus via anti-inflammation and modulating gut microbiota in rats. Lipids in Health and Disease, 19, 1\u201316.","journal-title":"Lipids in Health and Disease"},{"issue":"1","key":"10958_CR118","doi-asserted-by":"publisher","first-page":"8879227","DOI":"10.1155\/2021\/8879227","volume":"2021","author":"Y Fu","year":"2021","unstructured":"Fu, Y., et al. (2021). Associations among dietary omega-3 polyunsaturated fatty acids, the gut microbiota, and intestinal immunity. Mediators of Inflammation, 2021(1), 8879227.","journal-title":"Mediators of Inflammation"},{"key":"10958_CR119","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.abst.2024.02.001","volume":"6","author":"IA Onifade","year":"2024","unstructured":"Onifade, I. A., et al. (2024). Faecal microbial transplant. Advances in Biomarker Sciences and Technology, 6, 20\u201334.","journal-title":"Advances in Biomarker Sciences and Technology"},{"key":"10958_CR120","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12081871","author":"E Zikou","year":"2024","unstructured":"Zikou, E., Koliaki, C., & Makrilakis, K. (2024). The role of fecal microbiota transplantation (FMT) in the management of metabolic diseases in humans: A narrative review. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines12081871","journal-title":"Biomedicines"},{"issue":"8","key":"10958_CR121","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.jtct.2023.05.007","volume":"29","author":"AN Gray","year":"2023","unstructured":"Gray, A. N., & DeFilipp, Z. (2023). Fecal microbiota transplantation for acute graft-versus-host disease after allogeneic hematopoietic cell transplantation: Expanding the horizon into pediatrics. Transplantation and Cellular Therapy,29(8), 484\u2013491.","journal-title":"Transplantation and Cellular Therapy"},{"issue":"21","key":"10958_CR122","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1056\/NEJMoa1910437","volume":"381","author":"Z DeFilipp","year":"2019","unstructured":"DeFilipp, Z., Bloom, P. P., Torres Soto, M., Mansour, M. K., Sater, M. R. A., Huntley, M. H., Turbett, S., Chung, R. T., Chen, Y. B., & Hohmann, E. L. (2019). Drug-resistant E. coli bacteremia transmitted by fecal microbiota transplant. New England Journal of Medicine,381(21), 2043\u20132050.","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10958_CR123","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-068480","volume":"13","author":"A Doug\u00e9","year":"2023","unstructured":"Doug\u00e9, A., et al. (2023). Faecal microbiota transplantation to prevent complications after allogeneic stem cell transplantation for haematological malignancies: A study protocol for a randomised controlled phase-II trial (the FMT-allo study). BMJ Open,13(5), Article e068480.","journal-title":"BMJ Open"},{"issue":"Supplement 1","key":"10958_CR124","doi-asserted-by":"publisher","first-page":"4869","DOI":"10.1182\/blood-2021-151904","volume":"138","author":"H Aslam","year":"2021","unstructured":"Aslam, H., Veeraballi, S., & Hashmi, S. K. (2021). Fecal microbiota transplantation as a therapeutic option for graft-versus-host-disease: A systematic review and future directions. Blood,138(Supplement 1), 4869\u20134869.","journal-title":"Blood"},{"issue":"6","key":"10958_CR125","doi-asserted-by":"publisher","first-page":"030006052092569","DOI":"10.1177\/0300060520925693","volume":"48","author":"MM Biernat","year":"2020","unstructured":"Biernat, M. M., et al. (2020). Fecal microbiota transplantation in the treatment of intestinal steroid-resistant graft-versus-host disease: Two case reports and a review of the literature. Journal of International Medical Research, 48(6), 0300060520925693.","journal-title":"Journal of International Medical Research"},{"issue":"16","key":"10958_CR126","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1182\/blood-2016-05-717652","volume":"128","author":"K Kakihana","year":"2016","unstructured":"Kakihana, K., et al. (2016). Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut. Blood, 128(16), 2083\u20132088.","journal-title":"Blood"},{"issue":"2","key":"10958_CR127","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3390\/jpm11020100","volume":"11","author":"A Pession","year":"2021","unstructured":"Pession, A., et al. (2021). Fecal microbiota transplantation in allogeneic hematopoietic stem cell transplantation recipients: A systematic review. Journal of Personalized Medicine, 11(2), 100.","journal-title":"Journal of Personalized Medicine"},{"issue":"34","key":"10958_CR128","doi-asserted-by":"publisher","first-page":"5306","DOI":"10.1200\/JCO.22.02366","volume":"41","author":"A Rashidi","year":"2023","unstructured":"Rashidi, A., et al. (2023). Randomized double-blind phase II trial of fecal microbiota transplantation versus placebo in allogeneic hematopoietic cell transplantation and AML. Journal of Clinical Oncology,41(34), 5306\u20135319.","journal-title":"Journal of Clinical Oncology"},{"issue":"4","key":"10958_CR129","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/tid.12550","volume":"18","author":"BJ Webb","year":"2016","unstructured":"Webb, B. J., et al. (2016). Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients. Transplant Infectious Disease,18(4), 628\u2013633.","journal-title":"Transplant Infectious Disease"},{"issue":"556","key":"10958_CR130","doi-asserted-by":"publisher","first-page":"eaaz8926","DOI":"10.1126\/scitranslmed.aaz8926","volume":"12","author":"YF van Lier","year":"2020","unstructured":"van Lier, Y. F., et al. (2020). Donor fecal microbiota transplantation ameliorates intestinal graft-versus-host disease in allogeneic hematopoietic cell transplant recipients. Science Translational Medicine, 12(556), eaaz8926.","journal-title":"Science Translational Medicine"},{"issue":"3","key":"10958_CR131","doi-asserted-by":"publisher","DOI":"10.1016\/j.infpip.2020.100069","volume":"2","author":"B Merrick","year":"2020","unstructured":"Merrick, B., et al. (2020). Regulation, risk and safety of faecal microbiota transplant. Infection Prevention in Practice,2(3), Article 100069.","journal-title":"Infection Prevention in Practice"},{"key":"10958_CR132","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1016\/j.jfma.2018.08.011","volume":"118","author":"JW Wang","year":"2019","unstructured":"Wang, J. W., et al. (2019). Fecal microbiota transplantation: Review and update. Journal of the Formosan Medical Association, 118, S23\u2013S31.","journal-title":"Journal of the Formosan Medical Association"},{"issue":"6","key":"10958_CR133","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.3390\/jcm9061757","volume":"9","author":"S Bibb\u00f2","year":"2020","unstructured":"Bibb\u00f2, S., et al. (2020). Fecal microbiota transplantation: Screening and selection to choose the optimal donor. Journal of Clinical Medicine, 9(6), 1757.","journal-title":"Journal of Clinical Medicine"},{"key":"10958_CR134","doi-asserted-by":"crossref","unstructured":"Gaonkar, P. (2021). Safety and Potential Risks with Fecal Microbiota Transplantation, in Contemporary Topics in Patient Safety - Volume 1, S.P. Stawicki and M.S. Firstenberg, Editors. IntechOpen: Rijeka.","DOI":"10.5772\/intechopen.95907"},{"issue":"2","key":"10958_CR135","doi-asserted-by":"publisher","first-page":"e00161","DOI":"10.1128\/JCM.00161-21","volume":"60","author":"N Mehta","year":"2022","unstructured":"Mehta, N., et al. (2022). Fecal microbiota transplantation donor screening updates and research gaps for solid organ transplant recipients. Journal of Clinical Microbiology, 60(2), e00161\u2013e00121.","journal-title":"Journal of Clinical Microbiology"},{"key":"10958_CR136","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2023-062922","author":"M Oliva-Hemker","year":"2023","unstructured":"Oliva-Hemker, M. (2023). Fecal microbiota transplantation: Information for the pediatrician. Pediatrics. https:\/\/doi.org\/10.1542\/peds.2023-062922","journal-title":"Pediatrics"},{"key":"10958_CR137","doi-asserted-by":"publisher","DOI":"10.3390\/diseases8020009","author":"C Nicco","year":"2020","unstructured":"Nicco, C. (2020). From donor to patient: Collection, preparation and cryopreservation of fecal samples for fecal microbiota transplantation. Diseases. https:\/\/doi.org\/10.3390\/diseases8020009","journal-title":"Diseases"},{"issue":"2","key":"10958_CR138","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s10620-020-06185-7","volume":"66","author":"D Ramai","year":"2021","unstructured":"Ramai, D., et al. (2021). Fecal microbiota transplantation (FMT) with colonoscopy is superior to enema and nasogastric tube while comparable to capsule for the treatment of recurrent clostridioides difficile infection: A systematic review and meta-analysis. Digestive Diseases and Sciences,66(2), 369\u2013380.","journal-title":"Digestive Diseases and Sciences"},{"issue":"8","key":"10958_CR139","doi-asserted-by":"publisher","first-page":"e0161174","DOI":"10.1371\/journal.pone.0161174","volume":"11","author":"S Wang","year":"2016","unstructured":"Wang, S., et al. (2016). Systematic review: Adverse events of fecal microbiota transplantation. PLoS One, 11(8), e0161174.","journal-title":"PLoS One"},{"issue":"5","key":"10958_CR140","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2024.105341","volume":"26","author":"D Rondinella","year":"2024","unstructured":"Rondinella, D., et al. (2024). Donor screening for fecal microbiota transplantation with a direct stool testing-based strategy: A prospective cohort study. Microbes and Infection,26(5), Article 105341.","journal-title":"Microbes and Infection"},{"key":"10958_CR141","doi-asserted-by":"publisher","first-page":"101758","DOI":"10.1016\/j.biologicals.2024.101758","volume":"86","author":"I Belotserkovsky","year":"2024","unstructured":"Belotserkovsky, I., et al. (2024). Standards for fecal microbiota transplant: Tools and therapeutic advances. Biologicals, 86, 101758.","journal-title":"Biologicals"},{"issue":"2","key":"10958_CR142","doi-asserted-by":"publisher","first-page":"e00060","DOI":"10.1128\/cmr.00060-22","volume":"37","author":"A Yadegar","year":"2024","unstructured":"Yadegar, A., et al. (2024). Fecal microbiota transplantation: Current challenges and future landscapes. Clinical Microbiology Reviews, 37(2), e00060\u2013e00022.","journal-title":"Clinical Microbiology Reviews"},{"issue":"10","key":"10958_CR143","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.1128\/AEM.00256-13","volume":"79","author":"D Ercolini","year":"2013","unstructured":"Ercolini, D. (2013). High-throughput sequencing and metagenomics: Moving forward in the culture-independent analysis of food microbial ecology. Applied and Environment Microbiology, 79(10), 3148\u20133155.","journal-title":"Applied and Environment Microbiology"},{"key":"10958_CR144","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/proteomes12030025","volume":"12","author":"R Vitorino","year":"2024","unstructured":"Vitorino, R. (2024). Transforming clinical research: The power of high-throughput omics integration. Proteomes,12, 25.","journal-title":"Proteomes"},{"key":"10958_CR145","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.766364","author":"L Zhang","year":"2021","unstructured":"Zhang, L. (2021). Advances in metagenomics and its application in environmental microorganisms. Frontiers in Microbiology. https:\/\/doi.org\/10.3389\/fmicb.2021.766364","journal-title":"Frontiers in Microbiology"},{"issue":"4","key":"10958_CR146","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1128\/MMBR.68.4.669-685.2004","volume":"68","author":"J Handelsman","year":"2004","unstructured":"Handelsman, J. (2004). Metagenomics: Application of genomics to uncultured microorganisms. Microbiology and Molecular Biology Reviews, 68(4), 669\u2013685.","journal-title":"Microbiology and Molecular Biology Reviews"},{"issue":"5","key":"10958_CR147","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nmeth.f.303","volume":"7","author":"JG Caporaso","year":"2010","unstructured":"Caporaso, J. G., et al. (2010). QIIME allows analysis of high-throughput community sequencing data. Nature Methods, 7(5), 335\u2013336.","journal-title":"Nature Methods"},{"issue":"1","key":"10958_CR148","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s40168-022-01412-x","volume":"10","author":"J Shen","year":"2022","unstructured":"Shen, J., et al. (2022). An improved workflow for accurate and robust healthcare environmental surveillance using metagenomics. Microbiome, 10(1), 206.","journal-title":"Microbiome"},{"issue":"1","key":"10958_CR149","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41392-023-01309-7","volume":"8","author":"T Li","year":"2023","unstructured":"Li, T., et al. (2023). CRISPR\/Cas9 therapeutics: Progress and prospects. Signal Transduction and Targeted Therapy, 8(1), 36.","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10958_CR150","doi-asserted-by":"publisher","DOI":"10.3389\/fgeed.2020.617910","author":"D Allen","year":"2021","unstructured":"Allen, D., Rosenberg, M., & Hendel, A. (2021). Using synthetically engineered guide RNAs to enhance CRISPR genome editing systems in mammalian cells. Frontiers in Genome Editing. https:\/\/doi.org\/10.3389\/fgeed.2020.617910","journal-title":"Frontiers in Genome Editing"},{"issue":"4","key":"10958_CR151","first-page":"933","volume":"106","author":"I Henig","year":"2021","unstructured":"Henig, I., Yehudai-Ofir, D., & Zuckerman, T. (2021). The clinical role of the gut microbiome and fecal microbiota transplantation in allogeneic stem cell transplantation. Haematologica,106(4), 933\u2013946.","journal-title":"Haematologica"},{"issue":"1","key":"10958_CR152","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.chom.2020.10.010","volume":"29","author":"PC M\u00fcnch","year":"2021","unstructured":"M\u00fcnch, P. C., et al. (2021). Identification of natural CRISPR systems and targets in the human microbiome. Cell Host & Microbe,29(1), 94\u2013106e4.","journal-title":"Cell Host & Microbe"},{"issue":"1772","key":"10958_CR153","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2018.0103","volume":"374","author":"G Ramachandran","year":"2019","unstructured":"Ramachandran, G., & Bikard, D. (2019). Editing the microbiome the CRISPR way. Philosophical Transactions of the Royal Society B: Biological Sciences,374(1772), Article 20180103.","journal-title":"Philosophical Transactions of the Royal Society B: Biological Sciences"},{"issue":"15","key":"10958_CR154","doi-asserted-by":"publisher","first-page":"3612","DOI":"10.3390\/cancers14153612","volume":"14","author":"R Ancos-Pintado","year":"2022","unstructured":"Ancos-Pintado, R., et al. (2022). High-throughput CRISPR screening in hematological neoplasms. Cancers,14(15), 3612.","journal-title":"Cancers"},{"issue":"7","key":"10958_CR155","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.4103\/jcrt.jcrt_33_24","volume":"20","author":"Z Guo","year":"2024","unstructured":"Guo, Z., et al. (2024). The role of fecal microbiota transplantation in the treatment of acute graft-versus-host disease. Journal of Cancer Research and Therapeutics, 20(7), 1964\u20131973.","journal-title":"Journal of Cancer Research and Therapeutics"},{"key":"10958_CR156","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/978-1-0716-3658-9_7","volume":"2760","author":"M Kang","year":"2024","unstructured":"Kang, M., Kim, K., & Cho, B. K. (2024). CRISPRi-driven genetic screening for designing novel microbial phenotypes. Methods in Molecular Biology,2760, 117\u2013132.","journal-title":"Methods in Molecular Biology"},{"issue":"2","key":"10958_CR157","doi-asserted-by":"publisher","first-page":"e0017022","DOI":"10.1128\/mmbr.00170-22","volume":"88","author":"AL Enright","year":"2024","unstructured":"Enright, A. L., et al. (2024). CRISPRi functional genomics in bacteria and its application to medical and industrial research. Microbiology and Molecular Biology Reviews, 88(2), e0017022.","journal-title":"Microbiology and Molecular Biology Reviews"},{"issue":"11","key":"10958_CR158","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.3390\/microorganisms12112256","volume":"12","author":"S Biennier","year":"2024","unstructured":"Biennier, S., et al. (2024). Narrative review: Advancing dysbiosis treatment in onco-hematology with microbiome-based therapeutic approach. Microorganisms,12(11), 2256.","journal-title":"Microorganisms"},{"issue":"4","key":"10958_CR159","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1053\/j.gastro.2016.11.010","volume":"152","author":"SJ Ott","year":"2017","unstructured":"Ott, S. J., et al. (2017). Efficacy of sterile fecal filtrate transfer for treating patients with clostridium difficile infection. Gastroenterology, 152(4), 799\u2013811. e7.","journal-title":"Gastroenterology"},{"key":"10958_CR160","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.3389\/fmicb.2017.01162","volume":"8","author":"VK Gupta","year":"2017","unstructured":"Gupta, V. K., Paul, S., & Dutta, C. (2017). Geography, ethnicity or subsistence-specific variations in human microbiome composition and diversity. Frontiers in Microbiology,8, 1162.","journal-title":"Frontiers in Microbiology"},{"issue":"7402","key":"10958_CR161","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature11053","volume":"486","author":"T Yatsunenko","year":"2012","unstructured":"Yatsunenko, T., et al. (2012). Human gut microbiome viewed across age and geography. Nature,486(7402), 222\u2013227.","journal-title":"Nature"},{"key":"10958_CR162","doi-asserted-by":"crossref","unstructured":"Van Lier, Y. F. (2021). The post-hematopoietic cell transplantation microbiome: relationships with transplant outcome and potential therapeutic targets.\u00a0Haematologica, 106(8), 2042","DOI":"10.3324\/haematol.2020.270835"}],"container-title":["Stem Cell Reviews and Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-025-10958-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12015-025-10958-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-025-10958-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T04:03:01Z","timestamp":1759896181000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12015-025-10958-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,4]]},"references-count":162,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10958"],"URL":"https:\/\/doi.org\/10.1007\/s12015-025-10958-w","relation":{},"ISSN":["2629-3269","2629-3277"],"issn-type":[{"value":"2629-3269","type":"print"},{"value":"2629-3277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,4]]},"assertion":[{"value":"1 August 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Number"}}]}}